The Effect of Obesity on the State of Platelet-plasma Hemostasis in Patients with Essential Hypertension in Combination with Non-alcoholic Fatty Liver Disease
Open Access
- 30 October 2020
- journal article
- Published by Professional Event, LLC in Family Medicine
- No. 4,p. 56-62
- https://doi.org/10.30841/2307-5112.4.2020.217657
Abstract
Obesity, being one of the main modified risk factors for the development of pathology of the cardiovascular system, determines its rapid progression, more severe course and a high incidence of complications. With the prevalence of obesity, the incidence of hypertension (HT), non-alcoholic fatty liver disease (NAFLD), and, as a result, cardiovascular events increases. The objective: To increase the efficiency of early diagnosis of thrombophilic changes in the blood in patients with essential hypertension and concomitant obesity, combined with non-alcoholic fatty liver disease. Materials and methods. The study was conducted on the clinical base of the Department of Propedeutics of Internal Medicine No. 1 of the Bogomolets National Medical University in Kiev Clinical Hospital on railway transport No. 2 Branch «Center for Health Protection» of PJSC «Ukrainian Railway». 152 patients were examined: 72 men and 80 women. The patients were divided into groups: Group I – patients with stage II hypertension without signs of liver damage (46 people); Group II – patients with NAFLD without HT (54 people); Group III – patients with stage II HD with NAFLD (52 people). Results. In the group of NAFLD patients without concomitant hypertension, the effect of obesity was observed both on the platelet count and on their mean volume. The platelet count was significantly higher in the presence of obesity – it was 16 % ( Conclusion. Addition of obesity to hypertension and to the comorbid course of hypertension with NAFLD increased the thrombogenic activity of the blood, affecting various stages of hemostasis. However, the indicators of platelet-plasma hemostasis in patients with independent NAFLD did not actually differ from patients with obesity and BM I<30 kg/m2, which indicates similar pathophysiological mechanisms of prothrombotic changes in obesity and NAFLD.Keywords
This publication has 11 references indexed in Scilit:
- Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?Current Pharmaceutical Design, 2020
- Mechanisms of NAFLD development and therapeutic strategiesNature Medicine, 2018
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender VariancesThe American Journal of Gastroenterology, 2018
- Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitisClinical and Translational Gastroenterology, 2018
- Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and OutcomesDigestive Diseases and Sciences, 2017
- Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosisWorld Journal of Hepatology, 2017
- American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with ObesityEndocrine Practice, 2016
- Potential for Dietary ω-3 Fatty Acids to Prevent Nonalcoholic Fatty Liver Disease and Reduce the Risk of Primary Liver CancerAdvances in Nutrition: An International Review Journal, 2015
- Global Burden of Cardiovascular Disease and Stroke: Hypertension at the CoreCanadian Journal of Cardiology, 2015
- Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitisJournal of Hepatology, 2013